4min chapter

In Good Company with Nicolai Tangen cover image

HIGHLIGHTS: David Ricks - CEO of Eli Lilly

In Good Company with Nicolai Tangen

CHAPTER

Transformative Benefits of Diabetes Medication and the Role of AI in Drug Development

This chapter explores the surprising weight loss benefits of a diabetes medication not originally intended for that purpose. It also examines how advances in treatments and AI's role in drug development could revolutionize weight management and reduce overall healthcare costs.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode